Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 15/20 | 0.63 |
| ▸ | RXRG | P48443 | 7/20 | 0.52 |
| ▸ | RXRB | P28702 | 6/20 | 0.47 |
| ▸ | CYP26A1 | O43174 | 2/20 | 0.34 |
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.34 |
| ▸ | RARB | P10826 | 6/20 | 0.32 |
| ▸ | RARG | P13631 | 6/20 | 0.32 |
| ▸ | RARA | P10276 | 5/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | GMNN | O75496 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL112943 | 1.00 | RXRA (0.63) | RXRARXRGRXRBCYP26A1CYP26B1 | |
| SCHEMBL3633427 | 0.89 | RXRA (0.65) | RXRARXRGRXRBRARBRARG | |
| SCHEMBL7081379 | 0.87 | RXRA (0.59) | RXRARXRGRXRBCYP26A1RARB | |
| SCHEMBL7081382 | 0.87 | RXRA (0.59) | RXRARXRGRXRBCYP26A1RARB | |
| SCHEMBL5478797 | 0.84 | RXRA (0.49) | RXRARXRGRXRBKDM4ENPC1 | |
| SCHEMBL13807401 | 0.84 | RXRA (0.57) | RXRARXRGRXRBPTGS1PTGS2 | |
| SCHEMBL7085844 | 0.82 | RXRA (0.60) | RXRARXRGRXRB | |
| Acetic Acid SCHEMBL8421363 | 0.82 | RXRA (0.54) | RXRARXRGRXRBCYP26A1RARB | |
| SCHEMBL7088008 | 0.80 | RXRA (0.61) | RXRARXRGRXRBCYP26A1CYP26B1 | |
| SCHEMBL7085816 | 0.80 | RXRA (0.58) | RXRARXRGRXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4655373-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2025-12-03 | — | — | EP | claimed |
| CN-119206284-A | Method and system for quantifying intake intensity of fish shoal | 扬州大学 | 2024-12-27 | — | — | CN | claimed |
| EP-4438065-A2 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2024-10-02 | — | — | EP | claimed |
| WO-2024156688-A1 | BIODEGRADABLE PERFUME COMPOSITION | GIVAUDAN SA (CH) | 2024-08-02 | — | — | WO | claimed |
| CN-116041220-B | Preparation method of aryl substituted amide compound | 浙江工业大学 | 2024-05-03 | — | — | CN | claimed |
| CN-110414077-B | Load weighing method and system of loader | 中国铁路上海局集团有限公司科学技术研究所 | 2023-01-10 | — | — | CN | claimed |
| EP-4746844-A1 | PERSONAL CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2026-05-27 | — | — | EP | disclosed |
| CN-122094649-A | Personal care compositions | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4731617-A1 | USE OF DIHYDROPYRAN DERIVATIVES AS AROMA CHEMICALS | BASF SE (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-12613188-B2 | Methods and systems of enhancing electromagnetic radiation signals from extracellular vesicles | THE GENERAL HOSPITAL CORPORATION (US) | 2026-04-28 | — | — | US | disclosed |
| EP-4724434-A1 | AMBERGRIS ISOMERS AND MIXTURES THEREOF | Symrise AG (DE) | 2026-04-15 | — | — | EP | disclosed |
| EP-4709829-A1 | FILMS AND THEIR USE IN HOME CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2026-03-18 | — | — | EP | disclosed |
| US-20260071137-A1 | 5,5-DISUBSTITUED TETRAHYDROFURAN-2-ONE AS FRAGRANCE COMPOUNDS | SYMRISE AG (DE) | 2026-03-12 | — | — | US | disclosed |
| CN-114206306-A | Personal care compositions | 高露洁-棕榄公司 | 2022-03-18 | — | — | CN | disclosed |
| WO-2022053140-A1 | SURFACTANT CONTAINING FORMULATION OF PSEUDO-CERAMIDES | SYMRISE AG (DE) | 2022-03-17 | — | — | WO | disclosed |
| EP-3965834-A1 | MALODOR COUNTERACTING COMPOSITION AND AGENT AND THE USE THEREOF | ChemCom S.A. (BE) | 2022-03-16 | — | — | EP | disclosed |
| EP-3966301-A1 | COMPOUND AND DETERGENT COMPOSITION | UNILEVER GLOBAL IP LIMITED (GB) | 2022-03-16 | — | — | EP | disclosed |
| CN-110343116-B | Wild chrysanthemum extract, preparation method thereof and application thereof in preparation of medicine for treating nasopharyngeal carcinoma | 中山大学 | 2022-02-22 | — | — | CN | disclosed |
| EP-3313362-B1 | MUSK COMPOSITIONS AND METHODS OF USE THEREOF | TAKASAGO PERFUMERY CO LTD (JP) | 2022-02-09 | — | — | EP | disclosed |
| CN-112602290-B | Identity authentication method and device and readable storage medium | 华为技术有限公司 | 2022-02-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12613188-B2 | Methods and systems of enhancing electromagnetic radiation signals from extracellular vesicles | EPCAM, BRCA1, L1CAM | RXRA 816/4885RXRG 1024/4885RXRB 827/4885 |
| US-20260071137-A1 | 5,5-DISUBSTITUED TETRAHYDROFURAN-2-ONE AS FRAGRANCE COMPOUNDS | PRMT5, ACSL5, ELOVL5 | RXRA 1030/4885RXRG 1728/4885RXRB 1301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.